Abstract
This chapter discusses the biophysical methods for size distribution analysis of biopharmaceutical protein products. Protein aggregates, conformational variants, reversible self-association, fragments, and glycosylation are common contributors to size heterogeneity in protein pharmaceuticals. Size distribution analysis is essential to product understanding and for ensuring product quality during development. The choice of specific techniques for determination of size heterogeneity may not be straightforward due to a broad range of possible sizes from protein fragments to visible particles. We discuss commonly used biophysical methods for the determination of protein size distribution including size-exclusion chromatography, field-flow fractionation, sedimentation, light scattering, microscopy, light obscuration, electrical zone sensing, and mass spectrometry. The advantages and limitations of each method are also presented. A combination of several methods is often necessary to obtain a comprehensive view of size heterogeneity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Attri AK, Minton AP (2005) Composition gradient static light scattering: a new technique for rapid detection and quantitative characterization of reversible macromolecular hetero-Âassociations in solution. Anal Biochem 346:132–138
Bahr U, Rohling U, Lautz C, Strupat K, Schurenberg M, Hillenkamp F (1996) A charge detector for time-of-flight mass analysis of high mass ions produced by matrix-assisted laser desorption/ionization (MALDI). J Mass Spectrom Ion Process 153:9–21
Banyay M, Gilstring F, Hauzenberger E, Ofverstedt LG, Eriksson AB, Krupp JJ, Larsson O (2004) Three-dimensional imaging of in situ specimens with low-dose electron tomography to analyze protein conformation. Assay Drug Dev Technol 2:561–567
Barber TA, Lannis MD, Williams JG (1989) Method evaluation: automated microscopy as a compendial test for particulates in parenteral solutions. J Parenter Sci Technol 43:27–47
Bich C, Zenobi R (2009) Mass spectrometry of large complexes. Curr Opin Struct Biol 19:632–639
Burg TP, Godin M, Knudsen SM, Shen W, Carlson G, Foster JS, Babcock K, Manalis SR (2007) Weighing of biomolecules, single cells and single nanoparticles in fluid. Nature 446:1066–1069
Cao S, Pollastrini J, Jiang Y (2009a) Separation and characterization of protein aggregates and particles by field flow fractionation. Curr Pharm Biotechnol 10:382–390
Cao S, Jiao N, Jiang Y, Mire-Sluis A, Narhi LO (2009b) Sub-visible particle quantitation in protein therapeutics. Pharmeur Bio Sci Notes 2009:73–79
Cromwell ME, Hilario E, Jacobson F (2006a) Protein aggregation and bioprocessing. AAPS J 8:E572–E579
Cromwell MEM, Felten C, Flores H, Liu J, Shire SJ (2006b) Self-association of therapeutic proteins: implications for product development. In: Murphy RM, Tsai AM (eds) Misbehaving proteins: protein (Mis)folding, aggregation, and stability. Springer, New York
Engel A, Muller DJ (2000) Observing single biomolecules at work with the atomic force microscope. Nat Struct Biol 7:715–718
Fechner P, Boudier T, Mangenot S, Jaroslawski S, Sturgis JN, Scheuring S (2009) Structural information, resolution, and noise in high-resolution atomic force microscopy topographs. Biophys J 96:3822–3831
Filipe V, Hawe A, Jiskoot W (2010) Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res 27:796–810
Follmer C, Pereira FV, Da Silveira NP, Carlini CR (2004) Jack bean urease (EC 3.5.1.5) aggregation monitored by dynamic and static light scattering. Biophys Chem 111:79–87
Fujishita O, Sendo T, Hisazumi A, Otsubo K, Aoyama T, Oishi R (1995) The evaluation of sizing accuracy of particle counters for parenteral drugs. PDA J Pharm Sci Technol 49:267–271
Gabrielson JP, Brader ML, Pekar AH, Mathis KB, Winter G, Carpenter JF, Randolph TW (2007a) Quantitation of aggregate levels in a recombinant humanized monoclonal antibody formulation by size-exclusion chromatography, asymmetrical flow field flow fractionation, and sedimentation velocity. J Pharm Sci 96:268–279
Gabrielson JP, Randolph TW, Kendrick BS, Stoner MR (2007b) Sedimentation velocity analytical ultracentrifugation and SEDFIT/c(s): limits of quantitation for a monoclonal antibody system. Anal Biochem 361:24–30
Huang CT, Sharma D, Oma P, Krishnamurthy R (2009) Quantitation of protein particles in parenteral solutions using micro-flow imaging. J Pharm Sci 98:3058–3071
Jossang T, Feder J, Rosenqvist E (1988) Photon correlation spectroscopy of human IgG. J Protein Chem 7:165–171
Krutchinsky AN, Ayed A, Donald LJ, Ens W, Duckworth HW, Standing KG (2000) Studies of noncovalent complexes in an electrospray ionization/time-of-flight mass spectrometer. In: Chapman J (ed) Mass spectrometry of proteins and peptides. Humana Press, Totowa
Kukrer B, Filipe V, Duijn EV, Kasper PT, Vreeken RJ, Heck AJR, Jiskoot W (2010) Mass spectrometric analysis of intact human monoclonal antibody aggregates fractionated by size-Âexclusion chromatography. Pharm Res 27:2197–2204
Lee H, Kirchmeier M, Mach H (2011) Monoclonal antibody aggregation intermediates visualized by atomic force microscopy. J Pharm Sci 100:416–423
Litzen A, Walter JK, Krischollek H, Wahlund KG (1993) Separation and quantitation of monoclonal antibody aggregates by asymmetrical flow field-flow fractionation and comparison to gel permeation chromatography. Anal Biochem 212:469–480
Liu J, Andya JD, Shire SJ (2006) A critical review of analytical ultracentrifugation and field flow fractionation methods for measuring protein aggregation. AAPS J 8:E580–E589
Liu H, Gaza-Bulseco G, Lundell E (2008) Assessment of antibody fragmentation by reversed-Âphase liquid chromatography and mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 876:13–23
Mahler HC, Friess W, Grauschopf U, Kiese S (2009) Protein aggregation: pathways, induction factors and analysis. J Pharm Sci 98:2909–2934
Manta B, Obal G, Ricciardi A, Pritsch O, Denicola A (2011) Tools to evaluate the conformation of protein products. Biotechnol J 6:731–741
Moore JM, Patapoff TW, Cromwell ME (1999) Kinetics and thermodynamics of dimer formation and dissociation for a recombinant humanized monoclonal antibody to vascular endothelial growth factor. Biochemistry 38:13960–13967
Narhi LO, Jiang Y, Cao S, Benedek K, Shnek D (2009) A critical review of analytical methods for subvisible and visible particles. Curr Pharm Biotechnol 10:373–381
North SJ, Hitchen PG, Haslam SM, Dell A (2009) Mass spectrometry in the analysis of N-linked and O-linked glycans. Curr Opin Struct Biol 19:498–506
Oliva A, Llabres M, Farina JB (2004) Applications of multi-angle laser light-scattering detection in the analysis of peptides and proteins. Curr Drug Discov Technol 1:229–242
Pease LF 3rd, Elliott JT, Tsai DH, Zachariah MR, Tarlov MJ (2008) Determination of protein aggregation with differential mobility analysis: application to IgG antibody. Biotechnol Bioeng 101:1214–1222
Philo JS (2006) Is any measurement method optimal for all aggregate sizes and types? AAPS J 8:E564–E571
Philo JS (2009) A critical review of methods for size characterization of non-particulate protein aggregates. Curr Pharm Biotechnol 10:359–372
Rambaldi DC, Reschiglian P, Zattoni A (2011) Flow field-flow fractionation: recent trends in protein analysis. Anal Bioanal Chem 399:1439–1447
Rivas G, Stafford W, Minton AP (1999) Characterization of heterologous protein-protein interactions using analytical ultracentrifugation. Methods 19:194–212
Roux KH (1999) Immunoglobulin structure and function as revealed by electron microscopy. Int Arch Allergy Immunol 120:85–99
Sandin S, Öfverstedt L-G, Wikström A-C, Wrange Ö, Skoglund U (2004) Structure and flexibility of individual immunoglobulin G molecules in solution. Structure 12:409–415
Sharma DK, King D, Moore PD, Oma P, Thomas D (2007) Flow microscopy for particulate analysis in parenteral and pharmaceutical fluids. Eur J Parenter Pharm Sci 12:97–101
Tatford OC, Gomme PT, Bertolini J (2004) Analytical techniques for the evaluation of liquid protein therapeutics. Biotechnol Appl Biochem 40:67–81
Thomson NH (2005) Imaging the substructure of antibodies with tapping-mode AFM in air: the importance of a water layer on mica. J Microsc 217:193–199
Vendruscolo M (2007) Determination of conformationally heterogeneous states of proteins. Curr Opin Struct Biol 17:15–20
Wang YJ, Shahrokh Z, Vemuri S, Eberlein G, Beylin I, Busch M (1996) Characterization, stability, and formulations of basic fibroblast growth factor. Pharm Biotechnol 9:141–180
Wang G, Johnson AJ, Kaltashov IA (2011) Evaluation of electrospray ionization mass spectrometry as a tool for characterization of small soluble protein aggregates. Anal Chem 84:1718–1724
Washabaugh MW, Collins KD (1986) The systematic characterization by aqueous column chromatography of solutes which affect protein stability. J Biol Chem 261:12477–12485
Wen J, Arakawa T, Philo JS (1996) Size-exclusion chromatography with on-line light-scattering, absorbance, and refractive index detectors for studying proteins and their interactions. Anal Biochem 240:155–166
Wenzel RJ, Matter U, Schutheis L, Zenobi R (2005) Analysis of megadalton ions using cryodetection MALDI time-of-flight mass spectrometry. Anal Chem 77:4329–4337
Wu G, Hummel D, Herman A (1997) Analysis of the solution behavior of protein pharmaceuticals by laser light scattering photometry. ACS Symp Ser 675:168–185
Wuchner K, Buchler J, Spycher R, Dalmonte P, Volkin DB (2010) Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulation. J Pharm Sci 99:3343–3361
Yohannes G, Jussila M, Hartonen K, Riekkola ML (2011) Asymmetrical flow field-flow fractionation technique for separation and characterization of biopolymers and bioparticles. J Chromatogr A 1218:4104–4116
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wei, Z., Polozova, A. (2013). Biophysical Techniques for Protein Size Distribution Analysis. In: Narhi, L. (eds) Biophysics for Therapeutic Protein Development. Biophysics for the Life Sciences, vol 4. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4316-2_4
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4316-2_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4315-5
Online ISBN: 978-1-4614-4316-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)